Xeno Biosciences

Developer of transformational therapies for metabolic diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2015 groups5 employees language xenobiosciences.com

Innovation

2 patent families (2 granted) — focus: Human necessities; filing pace slowing. Cited 529 times.

YearFilings
20161
20171
20182
20192
20201
20211
20222
20251

Investor mix

8 investors on record; lead investors include Boston Harbor Angels.

Investor typeCountShare
Venture capital450%
Angel & family office450%
Coming soon